|[July 07, 2014]
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Blucora, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of July 14, 2014
NEW YORK --(Business Wire)--
Levi & Korsinsky announces that a class action lawsuit has been
commenced in the United States District Court for the Western District
of Washington on behalf of investors who purchased Blucora, Inc.
("Blucora" or the "Company") (NasdaqGS:BCOR) common stock between
November 5, 2013 and February 20, 2014.
For more information, click here: http://zlk.9nl.com/blucora-bcor.
The complaint alleges that throughout the Class Period defendants
misrepresented and/or failed to disclose that: (a) the Company's main
web properties were tied to malware, virues and browser hijackers; (b)
Blucora's search volumes had been boosted due to a rise in illicit
search traffic; (c) a significant portion of the Company's traffic was
derived from malware, illicit traffic, pirated content, and/or click
fraud; and (d) the Company's relationship with Google (News - Alert) was impaired and
thus Google was unlikely to renew its contract with the Company on the
same terms as previously arranged.
If you suffered a loss in Blucora you have until July 14, 2014 to
request that the Court appoint you as lead plaintiff. Your ability to
share in any recovery doesn't require that you serve as a lead
plaintiff. To obtain additional information, contact Joseph E. Levi,
Esq. either via email at email@example.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/blucora-bcor.
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please feel
free to contact any of the attorneys listed below. Attorney advertising.
Prior results do not guarantee similar outcomes.
[ Back To TMCnet.com's Homepage ]